Moreover, transforming growth factor (TGF)-β2 (TGF-β2) was confirmed as a new direct target of miR-153 in osteosarcoma, and miR-153 may suppress tumor growth and invasion by repressing the expression of TGF-β2. This evidence concerns the gene TGFB2 and neoplasm.